Journal
JOURNAL OF NATURAL PRODUCTS
Volume 77, Issue 6, Pages 1275-1279Publisher
AMER CHEMICAL SOC
DOI: 10.1021/np400903w
Keywords
-
Funding
- Fundacao para a Ciencia e Tecnologia (FCT)
- POCI FEDER
- [PEst-OE/SAU/UI0177/2011]
- Fundação para a Ciência e a Tecnologia [PEst-OE/SAU/UI0177/2011] Funding Source: FCT
Ask authors/readers for more resources
BACE-1 is an aspartic protease involved in the conversion of amyloid precursor protein (APP) to amyloid-beta (A beta) in vivo, which is one of the key steps in the development and progression of Alzheimer's disease. In a previous screening procedure for inhibitors of BACE-1 activity, the oil of Lavandula luisieri was identified as the most potent among several essential oils. The inhibitory effect of this essential oil on A beta production was also demonstrated in a cellular assay. The composition of the volatile oil and the isolation of the compound responsible for the inhibitory activity were also reported. The present work focused on the characterization of the inhibition of BACE-1 by this active compound, a monoterpene necrodane ketone, 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone (1), with assessment of its K-i value and the type of inhibition. The dose-related effects of the compound were also evaluated using two different cell lines, with determinations of the respective EC50 values. The entire oil and the 2,3,4,4-tetramethy1-5-methylenecyclopent-2-enone (1) were tested on a triple transgenic mouse model of Alzheimer's disease. The overall results showed that compound 1 displayed a dose-dependent inhibition of BACE-1 in cellular and mouse models of Alzheimer's disease and is therefore capable of passing through cellular membranes and the blood brain barrier.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available